Literature DB >> 33213789

Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.

Michael B Cook1, Aaron P Thrift2.   

Abstract

In the United States, the incidence of esophageal adenocarcinoma increased markedly since the 1970s with a recent stabilization. Despite evolving screening and surveillance strategies to diagnose, risk triage, and intervene in Barrett's esophagus patients to prevent esophageal adenocarcinoma, most cases present with advanced disease and poor resultant survival. Epidemiologic studies have identified the main risk factors for these conditions, including increasing age, male sex, white race, gastroesophageal reflux disease, abdominal obesity, cigarette smoking, and lack of infection with Helicobacter pylori. This review summarizes the current epidemiologic evidence with implications for screening and surveillance in Barrett's esophagus and esophageal adenocarcinoma. Published by Elsevier Inc.

Entities:  

Keywords:  Algorithms; Biomarkers; Genetics; History; Incidence; Prevalence; Risk; Survival

Mesh:

Year:  2020        PMID: 33213789      PMCID: PMC7887893          DOI: 10.1016/j.giec.2020.08.001

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  179 in total

1.  Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.

Authors:  Erik J Snider; Griselda Compres; Daniel E Freedberg; Hossein Khiabanian; Yael R Nobel; Stephania Stump; Anne-Catrin Uhlemann; Charles J Lightdale; Julian A Abrams
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-29       Impact factor: 4.254

Review 2.  The Male Predominance in Esophageal Adenocarcinoma.

Authors:  Shao-Hua Xie; Jesper Lagergren
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-17       Impact factor: 11.382

3.  Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.

Authors:  Xiaohong Li; Thomas G Paulson; Patricia C Galipeau; Carissa A Sanchez; Karen Liu; Mary K Kuhner; Carlo C Maley; Steven G Self; Thomas L Vaughan; Brian J Reid; Patricia L Blount
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-30

4.  Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.

Authors:  Jessica L Petrick; Paula L Hyland; Patrick Caron; Roni T Falk; Ruth M Pfeiffer; Sanford M Dawsey; Christian C Abnet; Philip R Taylor; Stephanie J Weinstein; Demetrius Albanes; Neal D Freedman; Susan M Gapstur; Gary Bradwin; Chantal Guillemette; Peter T Campbell; Michael B Cook
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

5.  Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.

Authors:  A J Cameron; C T Lomboy; M Pera; H A Carpenter
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

6.  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Authors:  Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo C Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

7.  Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's Esophagus.

Authors:  Jon M Davison; John Goldblum; Udhayvir Singh Grewal; Kevin McGrath; Kenneth Fasanella; Christopher Deitrick; Aaron D DeWard; Emily A Bossart; Stephen L Hayward; Yi Zhang; Rebecca J Critchley-Thorne; Prashanthi N Thota
Journal:  Am J Gastroenterol       Date:  2020-06       Impact factor: 12.045

Review 8.  Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis.

Authors:  Vincent T Janmaat; Sophie H van Olphen; Katharina E Biermann; Leendert H J Looijenga; Marco B Bruno; Manon C W Spaander
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

9.  A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts.

Authors:  S J M Hoefnagel; N Mostafavi; M R Timmer; C T Lau; S L Meijer; K K Wang; K K Krishnadath
Journal:  PLoS One       Date:  2020-04-13       Impact factor: 3.240

10.  Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma.

Authors:  Swetha Kambhampati; Alan H Tieu; Brandon Luber; Hao Wang; Stephen J Meltzer
Journal:  Sci Rep       Date:  2020-03-17       Impact factor: 4.996

View more
  4 in total

1.  Prevalence and risk factors of barrett's esophagus in lynch syndrome.

Authors:  Natalie Farha; Ruishen Lyu; David Liska; Amit Bhatt; Carole Macaron; Carol A Burke
Journal:  Fam Cancer       Date:  2022-06-02       Impact factor: 2.375

2.  The Novel Conduit: Challenges of Esophagectomy After Bariatric Surgery.

Authors:  Michael Jureller; Shankar I Logarajah; Travis Allen Van Meter; Housam Osman; John Jay; Maitham Moslim; Ralph Aye; D Rohan Jeyarajah
Journal:  J Gastrointest Surg       Date:  2022-08-12       Impact factor: 3.267

3.  External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans.

Authors:  Theresa H Nguyen; Aaron P Thrift; Gyanprakash A Ketwaroo; Xianglin L Du; Luis Leon Novelo; Rollin George; Daniel G Rosen; Hashem B El-Serag
Journal:  Gastrointest Endosc       Date:  2022-01-06       Impact factor: 10.396

4.  Development of EndoScreen Chip, a Microfluidic Pre-Endoscopy Triage Test for Esophageal Adenocarcinoma.

Authors:  Julie A Webster; Alain Wuethrich; Karthik B Shanmugasundaram; Renee S Richards; Wioleta M Zelek; Alok K Shah; Louisa G Gordon; Bradley J Kendall; Gunter Hartel; B Paul Morgan; Matt Trau; Michelle M Hill
Journal:  Cancers (Basel)       Date:  2021-06-08       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.